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PPECIAL ARTICLE
Time of Accelerated
hange in Academic Cardiovascular Medicine
mplications for Academic Divisions
f Cardiology and Their Training Programs
obert M. Califf, MD, Thomas Ryan, MD, Pamela Douglas, MD, Pascal J. Goldschmidt-Clermont, MD
urham, North Carolina
With the vast epidemic of vascular disease predicted to be the leading cause of death and
disability by a growing margin over the next 30 years, academic medical centers with
cardiology training programs have a special responsibility. Given the dramatic advances of
biotechnology in producing highly effective but expensive strategies of prevention and
treatment, cardiovascular specialists should assist their academic centers in envisioning the
future to prepare trainees for a different environment. Cardiologists of the future must be able
to adapt to a societal need for patient-oriented, team-based clinical care and rapidly evolving
technology, while maintaining the fundamental skills and knowledge required for individual
patient interaction. Academic programs should benchmark their activities to ensure respon-
sible resource allocation so that cardiologists of the future will be trained in an environment
stimulating excellence and creativity. (J Am Coll Cardiol 2004;44:1957–65) © 2004 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.08.046American College of Cardiology Foundation
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iHE PROBLEM AND THE OPPORTUNITY
ascular disease is the leading cause of death and disability
n developed countries (1,2). With the explosion in the
umbers of elderly in the population coinciding with simul-
aneous epidemics of obesity, diabetes, and inactivity, this
attern will expand for the foreseeable future (3). Accord-
ngly, as the source of cardiovascular specialists, academic
ardiovascular programs and their associated training pro-
rams have a responsibility to orient their efforts toward
roducing specialists who can function effectively in this
pidemic situation.
In the face of the global epidemic of vascular disease, we
re entering an era of unparalleled opportunity to prevent
nd treat human disease (4), made possible by dramatic
dvances in our understanding of biology and engineering.
imultaneously, we are realizing that major gains could be
ade by more effective means of delivering existing knowl-
dge (5,6). Paradoxically, this success and opportunity is
reating the need for a different kind of cardiologist and a
ifferent approach to delivering cardiovascular care.
HE ENVIRONMENT
he technology that can be brought to bear by modern
ardiovascular medicine is truly astounding. Medical ther-
py with aspirin, statins, angiotensin-converting enzyme
nhibitors, and beta-blockers has produced substantial clin-
cal benefits (7), and devices including stents (not to
From the Duke Clinical Research Institute, the Duke Heart Center, and the
ivision of Cardiology, Duke University Medical Center, Durham, North Carolina.t
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ccepted August 12, 2004.ention drug-eluting stents), defibrillators, left ventricular
ssist devices, and off-pump surgery have recently yielded
ramatic reductions in age-specific death and disability
ates. Diagnostic modalities are becoming more accurate
nd less invasive. Within the next decade we expect to see
ffective remote monitoring, nanotechnology producing tiny
tools” to improve health and monitor biology, and perhaps
ell replacement therapy as realistic therapeutic approaches.
rrays of genes, proteins, and metabolites will be used to
ersonalize therapy for individual patients based on specific
isk assessment and expected response to therapy (8).
Partially as a result of this technology, people are living
onger than ever before, and they are more functional during
his longer lifespan. The current gains in longevity and
unctionality do not appear to be hitting a natural ceiling,
ut instead continue to increase. At the same time as the life
xpectancy of the average American is reaching beyond age
5 years, the birth rate is dropping. Within the next 30
ears, the Medicare population will double, while the
roportion of working people to Medicare recipients will
rop from 4:1 to 2:1. This increasingly elderly population
ill suffer from chronic diseases, and these population
rends will make vascular disease an even more dominant
ause of death and disability. Simultaneously, the expecta-
ions of this older population are high, with a strong societal
ovement toward consumerism in healthcare, leading to a
reater demand for the most current and technologically
ophisticated care available.
Additionally, the increasing capability of multiple sources
o measure health processes and outcomes has led to an
ncreasingly quantifiable view of quality (Fig. 1) (9). Al-
hough the individual practitioner will continue to be
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Future of Cardiology Training Programs November 16, 2004:1957–65ppreciated and valued, the primary assessment of the value
f health care will be based on independent measures
ocused on the system within a particular environment or
microenvironment” (10). In this context, medical quality
as been defined recently by the Institute of Medicine as
ncluding six key components (safety, efficacy, patient-
enteredness, timeliness, efficiency, and equitability) (Table
). Demonstrating progress toward optimizing these mea-
ures within the cardiovascular practice and as a component
f a larger health system will be an important challenge for
cademic centers, and training programs will need to incor-
orate teaching about the best ways to address these issues.
NEVITABLE REALITY
ver the past several decades, almost all aspects of cardio-
ascular medicine have undergone fundamental change. In
tark contrast to the dramatic improvements in our under-
tanding and treatment of cardiovascular disease, our ap-
roach to training physicians to practice cardiovascular care
as changed little over that same period. In light of all the
hanges in technology, the patient population, and the
ealth care environment, we cannot escape the conclusion
hat the current mode of training and practice in cardiovas-
ular medicine is in need of systemic reform. Indeed, if
xpected trends for the future are not taken into account in
esigning today’s training programs, we will face a widening
ap between the needs of society and the ability of the
rofession to respond.
Dramatic improvements in outcome are yet to come, and
Abbreviations and Acronyms
HF  heart failure
NIH  National Institutes of Health
igure 1. The cycle of quality portrays the steps in the development of
cientific constructs, evaluating them in clinical trials, constructing guide-
ines and performance measures based on the evidence, and measuring
doption into practice. Cardiovascular training programs should impart a
undamental understanding of this cycle into their trainees and develop
raining programs leading to expertise in each of the depicted areas,w
ncluding measurement of clinical quality. Reprinted with permission from
aliff et al. (9).hese will lead to increasing costs. The impact of new drugs
nd devices is just beginning to be felt, but the technological
evolution previously discussed will continue to bear fruit.
s a result, many more people with chronic disease in
eneral and with cardiovascular disease in particular, will be
eeking access to high-quality health care. Because the
ncremental benefit to be achieved almost always comes at
ncremental cost (11,12), overall costs are likely to rise. The
slope” of this relationship between increasing cost and
ocietal benefit will be scrutinized by payers in an attempt to
ationalize the costs of new technology and to justify the
xtent to which medical costs can be allowed to limit other
orms of societal spending (e.g., education, public safety, or
efense) (13,14). Even in cases where the short-term effect
s cost-saving, as in disease management programs for heart
ailure (HF), the end-of-life costs are simply deferred until
later time, when the aggregate costs may be higher (15).
hese increasing costs will inevitably increase the pressure
n the decisions made by the doctor, the patient, and the
ayer. Rather than simply providing the same services at a
aster rate, cardiovascular specialists of the future must
espond by developing novel approaches to the organization
f cardiovascular care.
There will not be enough cardiovascular specialists to
rovide services in the current configuration. After a decade
r more of predictions of physician oversupply, we now have
n extreme shortage of cardiovascular specialists (16–18). It
ppears certain over the next several years that the output of
.S.-based academic cardiology training programs will fail
o keep pace with the rate of retirement and death of
racticing cardiologists (17). Given what we know about the
nticipated population growth and demographic changes in
ur society, this fact has staggering implications for the
vailability of cardiovascular health care in the near future.
s effective technology becomes increasingly sophisticated,
he ability of the generalist to keep up with the advancing
echnology will be even further outpaced. Even if there were
widespread increase in training slots for cardiovascular
ellows, there would be no discernable impact, given the
urrent training approach, for almost a decade. Therefore,
able 1. Criteria for Evaluation of Clinical Care
alanced scorecard
Quality measures
Adherence to guidelines for effectiveness
Adherence to guidelines for safety
Finance
Revenue
Margin
Referral revenue and downstream revenue generated
Patient satisfaction
Timeliness
Subjective judgment of quality
Equitability
Employee satisfaction (how do coworkers and other care team
members evaluate the individual, practice group, or division)
.S. News and World Report rankinge need to simultaneously increase the number of cardio-
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November 16, 2004:1957–65 Future of Cardiology Training Programsascular specialists and develop new models of team care
hat produce measurable improvements in quality at a much
ower cost per unit of service delivery.
Imaging and disease markers will have a profound impact
n the near future. We are nearing an era in which
chocardiography will be handheld at the bedside, cardiac
tructure in three dimensions will be routinely accessible and
ransmissible over the Internet, and coronary artery obstruc-
ion will be directly measurable by noninvasive measures.
natomic imaging will give way to modalities that provide
combination of structural and metabolic information.
uch information, combined with genetic profiling, will
mprove our ability to tailor prevention and treatment
trategies for individual patients. The expense of these
maging methods will be enormous, but they will be
owerful stratifiers of risk, and they will detect disease
arlier and more definitively, often in a stage that would be
alled preclinical today. The ability to measure the concen-
ration of multiple proteins and metabolites at the same
ime will also allow for risk stratification and early disease
etection; the combination of these into molecular imaging
ill create substantial opportunities to target therapeutics
nd to measure the impact of treatment on biologic path-
ays. Yet today’s practitioners are poorly equipped to deal
ith this impending era of technology-based personalized
edicine.
The power of newer and more sophisticated technologies
ill not escape our consumer-oriented society (19). The
ery potency of technology increases both the benefit when
sed appropriately and the risk when used inappropriately.
ndeed, considering technologies such as mechanical or
iological heart replacement places a tremendous burden on
hose with the technological expertise (cardiovascular spe-
ialists) to use it wisely. Given the growing presence of the
nternet and the sophistication of media portrayals of these
ssues (20), the consumerism movement shows no sign of
lowing down. Although the engagement of patients in
heir own care is generally an improvement, the perception
f patients can be biased by societal dogma and by direct-
o-consumer advertising by the medical products industry.
uch expectations of intervention are also too often at the
enter of medical-legal conflicts. Although these problems
ave no easy solution, they reinforce the need for profes-
ional sources such as academic centers and professional
ocieties to create in-depth patient education, providing a
helter from commercial bias.
Whereas the upcoming generation of trainees generally
as the skills to use the Internet to their advantage, there is
gap between the possibilities of computerized learning and
he current offerings. Ranging from incremental “just-in-
ime” updating of knowledge (21) to simulation of proce-
ures (22–24), the possibilities for creating a more informed
ractitioner and a safer environment are evident. Training
rograms will need to take advantage of these technologic
dvances to reshape the long-term approach to expertise in
he profession. lAt the same time that the opportunities are greater than
ver before, the number of people filling academic cardiol-
gy positions nationally is inadequate. Nationwide, many
hief of cardiology positions are currently open, but lower-
evel faculty positions are even more plentiful, as the
hortage of cardiologists in practice is creating a renewed
idening of the income differential between academic
ardiovascular specialists and those in practice. The demand
or clinicians by large private groups is driving up the salaries
f entry-level cardiologists, making it increasingly challeng-
ng for academic programs to compete for young talent.
his phenomenon additionally threatens to limit the aca-
emic medical center as the source of future practitioners
ho need an environment in which to train.
HE SOLUTIONS
s we move into this technologically advanced era, training
nd practice must be aimed toward the construct of systems
ased on the cardiac care provider team, bound together by
odern information systems and stimulated by the dedica-
ion of individuals on that team to improving the lifespan
nd function of patients through personal responsibility and
eamwork. Many of the familiar routines of today’s cardi-
logists will need to be conducted by others with more
pecific but limited training, while the cardiologist increas-
ngly takes the role of “quarterback” of the delivery team in
ardiovascular medicine. Rather than working in isolation as
he sole dispenser of care, the cardiologist will focus more on
oordinating and overseeing the array of services that
onstitute the health care product.
he fundamentals. The fundamentals of bedside cardiol-
gy remain essential. For example, bedside diagnosis will be
upplemented, but not replaced, by an ability to perform
and-carried ultrasound (25). Thus, pragmatic training
hould take place despite full knowledge that the model for
ractice will undergo significant change. Integrating new
oncepts of practice and its organization with sound teach-
ng of today’s fundamentals will be an increasing challenge
or training programs. New areas of learning, from ethics to
conomics to clinical trial design, will be increasingly
alued.
As in all of medicine, cardiovascular medicine must
ddress the area of medical decision-making (26). Patients
eek out cardiovascular specialists partially because of their
echnical expertise gained from repetitive performance of
rocedures and evaluations—the importance of volume for
uality is now beyond doubt, although many other factors
lso contribute to quality (27)—however, advice from a
echnical expert about the use of powerful technology and
xpensive interventions is also of great importance. Despite
growing body of knowledge about the biology, psychology,
nd sociology of medical decision-making (28), surprisingly
ittle is taught in medical school or beyond to assist doctors
n their efforts to interact with patients, payers, and col-
eagues to navigate an increasingly complex array of choices.
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Future of Cardiology Training Programs November 16, 2004:1957–65nformation systems. Although doctors have grown weary
f comparisons with airline pilots, perhaps one area where
his common thinking should be embraced is in the arena of
ccess to information. We have recently become interested
n the construct that the doctor should operate in an
nvironment similar to the cockpit of an airplane. Before the
dvent of the modern cockpit, pilots were becoming over-
helmed with gauges and measurements that were not
rganized in a standardized fashion. Largely because of a
roject managed by the National Aeronautics and Space
dministration, the needs of pilots were meshed with the
echnology to produce the modern glass cockpit and the
utopilot.
Academic medical centers must become the engines of
hange in which new information systems are developed
nd tested. Although we and others encourage the National
nstitutes of Health (NIH), the Centers for Medicare and
edicaid Services, and the Food and Drug Administration
o play the role that the National Aeronautics and Space
dministration did in cockpit design (that is, provide
tandards based on solid research), living laboratories will be
eeded to do the evaluations and to develop novel systems.
imilar to the pilot, the modern clinician can be over-
helmed by the sheer volume of available data, varying in
uality, accuracy, and relevance. More information is not
lways in the best interest of either the patient or the
hysician. To take maximal advantage of this information
xplosion, we must create systems that allow new data to be
ltered, prioritized, and presented in context. The Internet,
ata-warehousing technology, and handheld devices will all
lay key roles in this regard. The widespread access to
ireless technology, allowing images and records to be
ransmitted in real time, may have an enormous impact both
or clinical and for research purposes. Thus, although
echnology per se could never be used as the primary means
or quality practice, when used strategically, it will have a
efining effect by producing technology-enabled clinicians
ather than practitioners like those today who are limited by
oor access to data that could markedly improve decision-
aking and communication.
LINICAL PRACTICE
iven the critical role of cardiovascular medicine in the
verall picture of clinical care delivery, top-notch academic
ivisions of cardiology must have excellent clinical practices.
he importance of a high-volume clinical practice in the
cademic medical center of the future is predicated on three
ssumptions: 1) that the highest-quality care (29,30) can be
rovided in an environment in which specialty expertise is
ibrant and well organized; 2) that quality is linked to
olume (31); and 3) that volume is necessary to provide
ptimal training for residents and fellows (32).
The cardiovascular specialties are continuing to sort into
ell-defined subspecialties, each with a large body of
nowledge and technical expertise. Interventional cardiol- sgy, electrophysiology, HF, and congenital and valvular
ardiology share common characteristics. Each area will see
ajor growth in patient volume over the next two decades,
ach is driven by increasingly sophisticated technology with
major impact on clinical outcome, and each is driven to
urther subspecialization by the complexity of the involved
echnology. These subspecialties also have in common the
eed for a firm base in fundamental clinical cardiology and
n increasing use of imaging to drive diagnosis and the
ssessment of progression of disease.
maging. The impact of imaging on cardiovascular medi-
ine has been underappreciated. Because of its portability
nd low cost, echocardiography will remain the workhorse
f cardiac imaging (33). Hand-carried devices will allow
chocardiography to be incorporated into the bedside eval-
ation of the patient. In addition to confirming information
leaned through the physical examination, point-of-care
ltrasound will extend bedside diagnosis to include direct
easurement of left ventricular and valvular function, there-
ore, profoundly affecting the training of future generations
f clinicians. At the same time, this trend will have
mportant consequences on the finances of hospitals and
ractices. Nuclear cardiology is practiced and taught by
adiologists in many academic medical centers, yet it is an
ntegral part of the modern practice of cardiology, and in
ractice is predominantly performed by cardiologists. How-
ver, the superiority of magnetic resonance (34,35) for
maging both structure and function is already evident, and
ts potential impact on the future of diagnostic imaging is
urrently being shaped. Computerized tomographic angiog-
aphy is likely to alter the practice of vascular medicine by
ffering a noninvasive method to diagnose obstructive dis-
ase on a mass scale.
Training of future cardiologists should consider both the
rowing variety and the increasing costs of diagnostic/
maging tools. Fellowship training for those interested in a
areer in imaging should provide a broad knowledge base
cross methods and exposure to the newest modalities.
rainees should focus less on the individual imaging tech-
iques and more on the clinical questions. An appreciation
f incremental cost, utility, cost-benefit balance, and down-
tream effects will be necessary for optimal use of diagnostic
esting. In order for this approach to work, institutional
eaders must create an environment in which experts in
ompeting technologies are rewarded for working together,
ather than one in which competition is the dominant
ode.
eneral cardiology. In the coming decades, perhaps no
ther specialist group will have more potential impact on
atient outcome and societal costs than the general cardi-
logist. The opportunity to control the referral patterns to
rocedural-based subspecialists, such as electrophysiologists
nd interventional cardiologists, has profound implications
or technology utilization. More importantly, recent studies
36–38) have demonstrated that effective primary and
econdary prevention strategies have a greater potential
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November 16, 2004:1957–65 Future of Cardiology Training Programsmpact on outcome than our current and traditional ap-
roaches to treating coronary disease. The general cardiol-
gist will likely play a primary role in devising and managing
ndividualized prevention strategies (39), relying on the
nternet and other members of the integrated health care
eam for maximal effectiveness. With respect to training,
eaching fellows about prevention is necessary but insuffi-
ient. They must also be taught how to deliver the message
o a naive and often unreceptive population. In addition to
ommunication skills with patients, fellows must be taught
he role of the cardiologist as a consultant, which will
ontinue to expand as the number of patients with heart
isease increases relative to the number of cardiologists.
uch more needs to be learned about the best approach to
ollaborative care between specialists and generalists, which
as been found to be superior in some studies (40). General
ardiologists can probably be trained in a short-track format
o accelerate the supply situation (41).
IRECTIONS IN RESEARCH
asic research. Basic research in a division of cardiology
as become much more complex because of the increasing
nterdigitation of the sciences. As described in detail by the
ngoing NIH Roadmap Initiative, findings stimulated by
esearch in one organ or tissue often have profound rele-
ance for other systems. A key challenge for cardiology has
een the prioritization of approaches to research. Training
f true clinician-scientists in the cardiovascular discipline
as become increasingly rare. Considering the formidable
uccess of clinical research and consequent evidence-based
edicine in the cardiovascular field, it is tempting to invest
ost of our physician research support at this level. This
ould leave PhD scientists with the large majority of NIH
unding for the performance of basic research on the
undamental mechanisms of disease. Hence, very few car-
iovascular physician trainees are developing expertise in
tudying the mechanism of disorders that constitute their
iscipline. We propose that abandoning basic research in
he cardiovascular field may result in unwanted
onsequences.
Key areas of basic research in cardiovascular medicine
nclude the now-traditional fields of receptor biology, cell
igure 2. Translational blocks identified by the Institute of Medicine Clin
hese blocks.ignaling and atherosclerosis physiology, HF pathophysiol- pgy, and “channelopathies” (ion channel function). How-
ver, in divisions of cardiology the major source of transla-
ion will come from teams that are able to be intertwined
ith major institutional resources along a continuum from
enomics to proteomics, metabolomics, cellulomics, trans-
enic models, and large animal models.
Cell therapy may have a transforming societal effect.
ndothelial progenitor cells produced by the bone marrow
ecome exhausted and/or incompetent after a lifetime of
xposure of the organism to risk factors for atherosclerosis,
nd intravenous administration of such cells to mice has
een found to improve both the process of arterial repair
nd that of angiogenesis for the ischemic heart (42,43).
erhaps most immediately within reach is the opportunity
o resume the endogenous production of endothelial pro-
enitor cells (44) by correcting risk factors and restoring the
alance between repair cell consumption and production,
uch that the repair process can be completed successfully.
As new molecules (ribonucleic acids, proteins, or metab-
lites) are being discovered as key modifiers of disease
rocesses, they may become not only targets for therapies,
ut also potential markers for the disease status. With the
evelopment of cardiovascular imaging via magnetic reso-
ance imaging or positron emission tomography scan, such
olecules, providing sufficient local concentration at the
evel of the diseased organs, can be tagged and localized by
uch high-powered technologies. Many more examples
ould be provided to illustrate the formidable growth of
ardiovascular basic research through applied genomics and
ther multidisciplinary approaches. Of certainty is the fact
hat laboratories working along the traditional “one disease,
ne gene, one pathway” model are highly unlikely to make
ubstantial contributions to our field when compared with
hose produced by multidisciplinary teams, despite the fact
hat a large fraction of the funding derived from NIH and
ther agencies is still targeting such investigative fossils.
ranslational research (block 1). The Clinical Research
oundtable recently identified two major blocks (Fig. 2) in
ranslating the findings of science in societal benefit through
linical practice (45). The first of these blocks is one of the
ost difficult areas of research today—the initial translation
rom bench to bedside. At one time, this effort was in the
esearch Roundtable. Training programs should be focused on overcomingical Rurview of academic medicine, but over the past 25 years,
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Future of Cardiology Training Programs November 16, 2004:1957–65he movement of intellectual property into small biotech-
ology and device companies has created an inefficient
ystem by default. A recent review of this situation and a
roposal to address it has been published (46,47). In
ssence, the future translational effort must combine creative
cience with expert technology transfer and highly skilled
uman research in an increasingly regulated environment.
his effort is expensive, however, requiring significant
nvestment in technology and people.
linical trials. Clinical trials will play an expanded role in
efining effective diagnostic and therapeutic strategies, and
hose who pay for health care are likely to increasingly rely
pon trial results expressed in the form of clinical practice
uidelines to determine reimbursement criteria (48). Tradi-
ionally, participation in clinical trials, especially those
unded by industry, has been regarded as a low-level
cademic pursuit. However, at the same time that generat-
ng and expressing new ideas and discoveries is recognized
s higher-level academic achievement, academic units must
e “team players” by participating in clinical trials that
efine effective therapies in the future. Recognizing that the
est diagnostic and therapeutic strategies remain unknown
epresents an important step in intellectual honesty that
hould be the basis of an academic clinical practice. Addi-
ionally, participation in a well-organized clinical research
ffort provides the vast majority of trainees who will go into
ractice with important orientation to the organization
eeded to do clinical research in practice with appropriate
afeguards and respect for the human subjects involved.
This role of the academic medical center as a site for
linical research has been used by many programs to
riangulate money into other missions (49). For many
easons, this is not appropriate, although a modest margin
an be made after appropriate investment in study coordi-
ators, financial systems, and institutional review boards to
nsure that the research is performed to the highest stan-
ards. In particular, the effort requires an organized group of
oordinators rather than the “mom-and-pop” model that
as often used in the past. The regulatory risk to the
nstitution is now enormous when an uninformed investi-
ator violates federal regulations (50,51), placing substantial
alue on group research efforts with professional study
oordinators and sophisticated regulatory affairs and audit-
ng functions.
As the number of clinical trials proliferates, leadership in
linical trials will be an increasingly important element of
cademic programs. Leading and coordinating clinical trials
s distinctly different from participating in clinical trials;
eaders will need to have a level of knowledge about trial
esign and execution that will require major investment of
ime and resources.
utcomes and economics. The basis for quality in cardio-
ascular practice stems from the integration of clinical
nowledge, clinical reasoning, evidence from clinical trials,
nderstanding of the organization and financing of health
are delivery, and access to modern information technologyhat can enable measurable attainment of professional stan-
ards. Thus, the support of research and teaching efforts
egarding outcome measurement and economics should be a
ritical part of every major training program. Training in
his arena, as in clinical trials, will require a team approach
ncluding clinical epidemiologists, biostatisticians, health
conomists, and health services researchers. Unfortunately,
his arena suffers from a major deficit in funding, both for
nitial training and for career development (52). Recent
eviews of the topic point to the critical need for academic
enters to create new approaches to sustaining clinical
esearch professionals (53).
ranslational research (block 2). The gap between what is
nown about medical quality and the reality of everyday
ractice is increasingly recognized. Cardiovascular programs
hould have a program in practice improvement in which
he faculty, other providers, and fellows participate. In the
reas of complex HF (40,54,55), diabetes (56), hypertension
57), and lipid management (58), strong data already exist
or superiority of the “cardiac team,” but much remains to be
earned about the best organization of delivery of cardiovas-
ular services.
INANCES
he complexity of academic medicine makes a simple
rofit-loss statement practically useless for a division of
ardiology. At a minimum, the division must know the
ombined financial picture of the cardiac services or heart
enter, considering hospital, outpatient, and professional
evenues and expenses. Otherwise, short-sighted efforts to
aximize profitability, service, or efficiency on one side of
he organization can lead to substantial unintended conse-
uences in another part.
On the professional side, cardiovascular medicine is
ivotal to the function of other specialties such as cardiac
urgery, cardiac anesthesiology, and pediatric cardiology,
hile also providing a magnet for primary care referrals to
he institution. The decline of procedural volume for coro-
ary bypass surgery is currently placing significant stress on
he professional relationships between cardiologists and
heir surgical colleagues, but similar stresses can occur
ithin cardiology groups about the division of labor with
egard to clinical activities with higher or lower remunera-
ion. For example, it can be argued that concentration of
nterventional procedures and echocardiographic reading
nto high-volume operators will improve the quality of each
ctivity for the entire division, but cardiologists who spend
heir time seeing patients in the clinic may work harder
hile generating substantially less revenue. Recognition of
he fundamental dependence of one group on another is
ritical to optimal patient care and the long-term viability of
he division. Financial and activity reports must be adequate
o allow fair distribution of labor and financial gain to
otivate behavior in the interest of the group.
A major issue at academic medical centers is the control
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November 16, 2004:1957–65 Future of Cardiology Training Programsf the technical fees for procedures. In clinical practice the
bility to collect for technical fees for nuclear cardiology,
chocardiography and cardiac catheterization in free-
tanding facilities is a major source of revenue for cardiol-
gists. In academic medical centers these fees are often
ollected by the medical center with no direct financial
eturn to the group that generates the revenue. Although
uch fees can be used to offset the extraordinary costs of the
ocietal obligations of academic medical centers, the situa-
ion leaves academic cardiologists at a disadvantage relative
o community-based practitioners and leads to a drain of
ffective practitioners from the academic environment and
nderinvestment in the clinical care system.
On the other hand, primary care physicians have legiti-
ate concerns that the majority of vascular disease and HF
s seen in primary care clinics, yet the high-revenue proce-
ures are in the hands of cardiologists. As the national
ealth care budget comes under increasing stress with the
ging of the population, the balance of reimbursement will
e fragile and unpredictable. Therefore, visionary academic
enters will develop financial systems that allow sustained
etwork-building between primary care and cardiovascular
pecialists, with shifting of revenue as needed to maintain
oth groups as financing vacillates. Ultimately, the interde-
endencies of the various groups must be taken into
ccount. Just as interventionalists rely on clinic-based car-
iologists for referral volume, so too do cardiologists depend
n primary care physicians, not only for referrals but also for
oint care of the growing population of patients with
ardiovascular diseases. Although payors have tended to-
ard an irrational approach to reimbursement that rewards
he use of procedures and technology at the expense of
ighly effective, simple interventions, providers must see
eyond their own profit-loss statement and recognize the
alue of a team-oriented approach to organizational finances
nd patient care.
The relationship between cardiology and radiology has
raditionally been strained, and significant challenges are on
he horizon. The issue of “control” of peripheral vascular
rocedures remains difficult. The revenues and reading
rivileges are unsettled in nuclear imaging, while echocar-
iography has become the domain of the cardiologist.
owever, the next major challenge will come as computed
omography angiography for noninvasive coronary imaging
nd cardiac structural assessment with magnetic resonance
maging become commonplace.
For all of these reasons, a cardiology program can make
trategic financial decisions only if it has an integrated
nancial view of the areas under its direct control as well as
he areas it affects both as a source of referrals and revenue
nd as a recipient of referrals and revenue.
SSESSMENT OF A PROGRAM
ocietal contribution. Because not-for-profit academic
edical centers achieve that status as a public good, theltimate goal is to contribute to the well-being of society.
easuring societal impact is not easy, but remaining bound
o the self-absorbed historical approaches to academic
valuation (publications, societies) is also probably no longer
ufficient. The ideal direct measure of improved health of
he local community, the country, and the world is beyond
he scope of any individual cardiology group, yet measures
n each sphere should take into account proxy measures for
mproved health outcomes.
pecific activities. Given the complexity of the mission,
he “balanced scorecard,” which attempts to depict the mix
f issues that must be addressed in clinical care, may provide
he best measure of success (Table 1). The quadrants of the
corecard feature financial measures such as volume of
atients and procedures and margin generated, and quality
easures such as adherence to guidelines and patient and
mployee satisfaction.
Basic research is difficult to quantify, although the very
op programs can easily tally measures of prestigious awards
nd peer-reviewed funding. A troublesome issue yet to be
ddressed by the NIH stems from the inability to share
nancial credit in joint projects within or between institu-
ions. Table 2 lists the typical criteria used to judge the
uccess of a basic research program.
The success of a translational research program requires
ew metrics, as recently outlined (46,47). Creativity in this
rena will likely distinguish successful cardiovascular train-
ng programs over the next decade.
Many of the same metrics are pertinent to clinical
esearch as to basic and translational research, although
thers may be different. Table 3 lists the primary criteria
hat may be considered. The asymmetry between the tried-
nd-true metrics for basic research and clinical research is
triking. Whereas election to key honorary professional
rganizations such as the American Society for Clinical
nvestigation, the Association of American Professors, and
able 2. Basic Research Measures
ational Institues of Health ranking
umber of members in major societies
American Society for Clinical Investigation
Association of American Professors
Institute of Medicine
umber of program project grants awarded
umber of patents executed
ublication numbers and qualities
able 3. Criteria for Evaluation of Clinical Research Quality
ederal funding
National Institutes of Health, Agency for Healthcare Research and
Quality, Department of Defense, Centers for Disease Control
ndustry funding
ublications
Number
Number in top-tiered clinical/cardiovascular journals: N Engl J Med,
JAMA, Lancet, Circulation, J Am Coll Cardiol
Number of times cited in American College of Cardiology/American Heart Association Clinical Practice Guidelines
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Future of Cardiology Training Programs November 16, 2004:1957–65he National Academy of Sciences have been successful
arkers of success in the sciences, these organizations have
ot rewarded clinical investigators to the same degree.
urthermore, impact factor as a measure of scientific pub-
ishing does not reward clinical research manuscripts to the
ame extent as fundamental research because of the lower
ensity of repetitive citations. Additionally, for better or
orse, the lay press remains the major source of information
or the public (59), including many public-policy makers.
herefore, we are now experimenting with the use of press
itations in addition to peer-reviewed publications in eval-
ating the impact of a clinical investigator working in
linical trials, outcomes, or population studies. Because so
uch of clinical research is dependent on effective team-
ork, we are now including evaluation by other team
embers, including fellow faculty and non-faculty, in the
ssessment of individual quality, although this criterion is
ore difficult to judge for a cardiology division as a whole.
ONFLICT OF INTEREST
he large amounts of money involved in academic cardiol-
gy make it a constant source of concern about conflict of
nterest (60). Conflict of interest is defined as a commitment
hat diverts a professional from the primary commitment of
he profession (in this case, service to patients). Many
ituations will arise in an excellent academic cardiology
ivision that require careful personal and institutional man-
gement. A robust system for reporting and evaluating
onflict of interest should be in place (61,62). A general
rinciple is that the cardiology group should strive to lead
he institution in the “transparency factor”—the degree to
hich financial and other transactions are available to the
nstitutions and among faculty colleagues.
UMMARY OF RECOMMENDATIONS
Increase the number of cardiovascular trainees, but num-
bers alone will not solve the problem; a mix is needed,
including general cardiologists focused on managing sys-
tems of care and subspecialists trained deeply in technol-
ogy and the principles of its use. The general cardiologist
may be trained in a shorter period of time, but successful
researchers will require considerable protected time for
training and career development.
Programs should strive for high volume with exemplary
quality improvement efforts in their own hospitals and
practices.
Programs should offer a spectrum of research opportuni-
ties:
● Basic research with an emphasis on “team science”;
● Clinical trials;
● Clinical epidemiology, outcomes, and health policy; and
● Clinical quality research.
Programs should explore novel methods of delivery of
cardiovascular care to produce approaches that will solve
1our current mismatch of cardiologists and people seeking
cardiovascular care, including better linkage between
practice and academic settings.
Programs should incorporate training about critical areas
of the future:
● Health care organization and delivery;
● Quality measurement; and
● Use of information technology to enable more efficient
practice.
Specific efforts are needed to create models of lifelong
learning.
Metrics should be used and compared to measure and
improve the balanced performance of training programs.
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